Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Natera  (Stock symbol: NTRA )

201 Industrial Road, Suite 410
San Carlos, CA 94070
USA
650) 249-9090
Website Company Summary Management Team
Board

Outside board: (May no longer be on the board) Roelof Botha (Sequoia Capital Partner) John Steuart (Claremont Creek Ventures Managing Partner) Gail Marcus (Exceptional Leaders International practice leader)
Company

Business description: Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
Partners include: LifeLabs
Capital

Rounds: 6
Recent Fundings: Apr 2015   May 2013
Capital raised: 154.1M
Last Round: 55.5M
Ownership: Public   Ipo Filing
Stock Symbol: NTRA
VCs include: Lightspeed Venture Partners Sequoia CapitalSofinnova Investments ;  Franklin Templeton OrbiMedAlafi Capital Claremont Creek VenturesFounders Fund;  Healthcor Partners Harmony Partners;  Huntington Reproductive Center;  Jennison Associates ;  RA Capital Management Butterfly Capital
Angels/other VCs: Marissa Mayer (Google)

Last Tweets


 

Last Mentions


Overview
Record updated: Jul 2022
Sector: Medical
Year Founded: 2007
Headcount: 2001-3000 as of Jul 2022
Rounds: 6
Recent Fundings: Apr 2015   May 2013
Capital Raised: 154.1M
Last Round: 55.5M
Ownership: Public   Ipo Filing
Stock Symbol: NTRA